- Home
- YMAB vs JOF Comparison
YMAB vs JOF Comparison
Compare YMAB & JOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YMAB
- JOF
- Stock Information
- Founded
- YMAB 2015
- JOF 1990
- Country
- YMAB United States
- JOF Japan
- Employees
- YMAB N/A
- JOF N/A
- Industry
- YMAB Biotechnology: Pharmaceutical Preparations
- JOF Trusts Except Educational Religious and Charitable
- Sector
- YMAB Health Care
- JOF Finance
- Exchange
- YMAB Nasdaq
- JOF Nasdaq
- Market Cap
- YMAB 270.5M
- JOF 220.2M
- IPO Year
- YMAB 2018
- JOF N/A
- Fundamental
- Price
- YMAB $5.72
- JOF $7.96
- Analyst Decision
- YMAB Strong Buy
- JOF
- Analyst Count
- YMAB 10
- JOF 0
- Target Price
- YMAB $21.10
- JOF N/A
- AVG Volume (30 Days)
- YMAB 542.6K
- JOF 43.9K
- Earning Date
- YMAB 03-04-2025
- JOF 01-01-0001
- Dividend Yield
- YMAB N/A
- JOF 3.33%
- EPS Growth
- YMAB N/A
- JOF N/A
- EPS
- YMAB N/A
- JOF N/A
- Revenue
- YMAB $84,553,000.00
- JOF N/A
- Revenue This Year
- YMAB $6.41
- JOF N/A
- Revenue Next Year
- YMAB $18.15
- JOF N/A
- P/E Ratio
- YMAB N/A
- JOF N/A
- Revenue Growth
- YMAB N/A
- JOF N/A
- 52 Week Low
- YMAB $5.60
- JOF $6.64
- 52 Week High
- YMAB $20.90
- JOF $8.04
- Technical
- Relative Strength Index (RSI)
- YMAB 35.08
- JOF 59.04
- Support Level
- YMAB $5.60
- JOF $7.89
- Resistance Level
- YMAB $6.57
- JOF $8.01
- Average True Range (ATR)
- YMAB 0.38
- JOF 0.10
- MACD
- YMAB 0.10
- JOF 0.01
- Stochastic Oscillator
- YMAB 11.43
- JOF 84.00
About YMAB Y-mAbs Therapeutics Inc.
Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.
About JOF Japan Smaller Capitalization Fund Inc
Japan Smaller Capitalization Fund Inc is a United States-based non-diversified, closed-end management investment company. Its investment objective is to seek long-term capital appreciation through investments in smaller capitalization Japanese equity securities. Its portfolio of investments consists of different sectors such as banks, chemicals, construction, electric appliances, financing business, food, Information and Communication, Utilities, Real Estate, and others.